Showing results (2021-2030 of 8,948) with videos related to

Sort By:
Pageof 895
Schizophrenia Research|March 16, 2023
Human stem cell-based models to study synaptic dysfunction and cognition in schizophrenia: A narrative reviewStephanie Santarriaga, Kaia Gerlovin, Yasmine Layadi, et al.
Schizophrenia Research|March 1, 2023
Ethnoracial discrimination and the development of suspiciousness symptoms in individuals at clinical high-risk for psychosisTimothy I Michaels, Ricardo E Carrión, Jean Addington, et al.
Schizophrenia Research|February 12, 2023
Associations between acceptance of the implausible bias, theory of mind and delusions in first-episode psychosis patients; A longitudinal studyJonatan M Panula, Maija Lindgren, Tuula Kieseppä, et al.
Schizophrenia Research|March 18, 2023
Linguistic correlates of suicidal ideation in youth at clinical high-risk for psychosisMatthew F Dobbs, Alessia McGowan, Alexandria Selloni, et al.
Schizophrenia Research|August 4, 2016
Risks associated with antipsychotic treatment in pregnancy: Comparative cohort studies based on electronic health recordsIrene Petersen, Cormac J Sammon, Rachel L McCrea, et al.
Schizophrenia Research|August 9, 2016
Safety and tolerability of long-acting injectable versus oral antipsychotics: A meta-analysis of randomized controlled studies comparing the same antipsychoticsFuminari Misawa, Taishiro Kishimoto, Katsuhiko Hagi, et al.
Schizophrenia Research|July 13, 2015
Brain structural correlates of schizotypy and psychosis proneness in a non-clinical healthy volunteer sampleIgor Nenadic, Carsten Lorenz, Kerstin Langbein, et al.
Schizophrenia Research|July 13, 2015
Metacognitive deficits predict future levels of negative symptoms in schizophrenia controlling for neurocognition, affect recognition, and self-expectation of goal attainmentPaul H Lysaker, Marina Kukla, Julien Dubreucq, et al.
Schizophrenia Research|July 14, 2015
Impaired motor performance in adolescents at familial high-risk for schizophreniaT C Manschreck, J Chun, A M Merrill, et al.
Schizophrenia Research|July 25, 2016
Antioxidant properties of atypical antipsychotic drugs used in the treatment of schizophreniaIzabela Sadowska-Bartosz, Sabina Galiniak, Grzegorz Bartosz, et al.
Pageof 895